Cary, NC, United States of America

King Pharmaceuticals Research and Development, Inc.


USPTO Granted Patents = 23

% Expired Patents = 73.9

Trademarks = 15

Forward Citations = 88

Loading Chart...
Loading Chart...

12 inventors (with patents filed for the assignee):

goldMedal Pier Giovanni Baraldi (16 out of 39 patents)

silverMedal Allan R Moorman (11 out of 11 patents)

bronzeMedal Pier Andrea Borea (9 out of 18 patents)

4.  Romeo Romagnoli (4 out of 11 patents)

5.  Edward Leung (3 out of 5 patents)

6.  Mojgan Aghazadeh Tabrizi (2 out of 2 patents)

7.  Delia Preti (2 out of 2 patents)

8.  Michael Scannell (1 out of 3 patents)

9.  Michael C Scaife (1 out of 3 patents)

10.  Charles C Davis (1 out of 1 patent)

11.  Thiagarajan Balasubramanian (1 out of 1 patent)

12.  Russell Outcalt (1 out of 1 patent)


23 patents:

Company Overview
King Pharmaceuticals Research and Development, Inc., based in Cary, North Carolina, specializes in the development and commercialization of innovative pharmaceutical products. The company focuses on therapeutic areas such as pain management, cardiovascular health, and central nervous system disorders. With a commitment to advancing healthcare solutions, King Pharmaceuticals leverages cutting-edge research and technology to enhance patient outcomes and address unmet medical needs in various markets.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

23 Patents

#9 in Cary, NC

#334 in North Carolina

#14,428 in US

#27,685 in the World

Cary, NC (US)
Cary, NC, United States of America
Forward Citations = 88

12 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: King Pharmaceuticals Research and Development, Inc.. Retrieved from https://idiyas.com/company/king-pharmaceuticals-research-and-development

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…